KFRE Equation Overestimates Kidney Failure Risk in the Oldest Patients
This limitation of the kidney failure risk equation may affect advanced care planning for the oldest patients with advanced CKD.
End-Stage Renal Disease
END-STAGE RENAL DISEASE
Disparities Found in Kidney Failure Treatment Early in COVID-19 Pandemic
Disruptions in end-stage kidney disease care disproportionately affected socially disadvantaged populations.
Belimumab May Help Preserve Kidney Function in Lupus Nephritis
The risk of lupus nephritis flares decreased with belimumab treatment, investigators reported.
Prostate Cancer Delays Kidney Transplantation, Ups Death Risk in Dialysis
Understanding how prostate cancer affects death after kidney failure is important for appropriate management and guideline development.
Iron Status, FGF23 Tied With Poor Cardiovascular, Kidney Outcomes in CKD
Emerging data demonstrate that iron is an important regulator of FGF23.
ESKD Treatment Dropped Sharply During Height of COVID-19 Pandemic
During the initial height of the pandemic in 2020, the documented incidence of end-stage kidney disease, defined as initiation of maintenance dialysis or receipt of a preemptive kidney transplant, decreased compared with corresponding periods during 2017-2019.
Race-Free GFR Equations Based on Creatinine Plus Cystatin C More Accurate
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
Hyperuricemia Is a Risk Factor for ESKD in Minimal Change Disease
This study is the first to find an association between hyperuricemia and MCD progression in adults.
Lower Post-Nephrectomy Kidney Function May Up ESKD Risk
New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators.
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in End-Stage Renal Disease
Loading... 
Loading...